Name: Latest research reports of Alembic Pharmaceuticals Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alembic Pharmaceuticals Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Mid-range Performer

923.0000 -17.05 (-1.81%)

NSE Sep 24, 2025 14:30 PM

29.21% Fall from 52W High

Volume: 66,161

Alembic Pharmaceuticals Ltd.

08 Nov 2023

923.00

-1.81%

Alembic Pharma (HOLD): Higher opex from new facilities to keep a lid on margins

Hold: Alembic Pharmaceuticals Ltd.

Target

BOB Capital Markets Ltd.

Q2 revenue ticked up 8% YoY as healthy sales in international markets supported by modest India business

Alembic Pharmaceuticals Ltd. is trading below all available SMAs